PDCD1 and Alzheimer disease: In this model, the immunosuppressive pathway involving the PD-1/PD-L1 checkpoint acts as neuroprotective pathway although in certain chronic diseases, such as AD pathogenesis, the activation of PD-1/PD-L1 signaling and its collaboration with immunosuppressive cells might enhance AD pathology.